Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 352 entries
View as:

A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema Participants

Phase: N/A Priority: Normal
NCT ID: NCT02093923 Org: User:
Start: 05/14/14 End: 05/18/15 Due: 05/18/16

EDEMA2: Evaluation of DX-88's Effect in Mitigating Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT01826916 Org: User:
Start: 11/01/03 End: 01/01/06 Due: 01/01/07

Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt)

Phase: N/A Priority: Normal
NCT ID: NCT02065401 Org: User:
Start: 02/28/14 End: 03/19/14 Due: 03/19/15

Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/Mesalamine

Phase: N/A Priority: Normal
NCT ID: NCT01402947 Org: User:
Start: 07/25/11 End: 08/30/11 Due: 08/30/12

Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01449240 Org: User:
Start: 11/12/12 End: 12/20/13 Due: 12/20/14

A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01952080 Org: User:
Start: 11/14/13 End: 01/09/15 Due: 01/09/16

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

Phase: N/A Priority: Normal
NCT ID: NCT03845400 Org: User:
Start: 03/30/19 End: 10/22/22 Due: 10/22/23

Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo

Phase: N/A Priority: Normal
NCT ID: NCT03004924 Org: User:
Start: 03/29/17 End: 10/01/18 Due: 10/01/19

Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep Loss

Phase: N/A Priority: Normal
NCT ID: NCT01096680 Org: User:
Start: 04/05/10 End: 07/18/10 Due: 07/18/11

A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants.

Phase: N/A Priority: Normal
NCT ID: NCT03918239 Org: User:
Start: 05/14/19 End: 11/13/19 Due: 11/13/20

Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT00446849 Org: User:
Start: 05/01/07 End: 08/17/09 Due: 08/17/10

Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH)

Phase: N/A Priority: Normal
NCT ID: NCT01099215 Org: User:
Start: 04/30/10 End: 10/31/12 Due: 10/31/13

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01436149 Org: User:
Start: 10/27/11 End: 12/23/13 Due: 12/23/14

Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease

Phase: N/A Priority: Normal
NCT ID: NCT01614574 Org: User:
Start: 03/02/12 End: 05/25/13 Due: 05/25/14

Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary Angioedema

Phase: N/A Priority: Normal
NCT ID: NCT01253382 Org: User:
Start: 06/01/12 End: - Due: -

AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184

Phase: N/A Priority: Normal
NCT ID: NCT01824446 Org: User:
Start: 05/01/13 End: 05/29/13 Due: 05/29/14

Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00072839 Org: User:
Start: 11/12/03 End: 07/28/05 Due: 07/28/06

Open Label Extension in Adults With Binge Eating Disorder (BED)

Phase: N/A Priority: Normal
NCT ID: NCT01657019 Org: User:
Start: 08/21/12 End: 10/21/14 Due: 10/21/15

Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD

Phase: N/A Priority: Normal
NCT ID: NCT00681811 Org: User:
Start: 02/20/08 End: 10/22/10 Due: 10/22/11

Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT00764868 Org: User:
Start: 11/13/08 End: 04/22/10 Due: 04/22/11

A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye

Phase: N/A Priority: Normal
NCT ID: NCT01743729 Org: User:
Start: 12/07/12 End: 10/01/13 Due: 10/01/14

Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase: N/A Priority: Normal
NCT ID: NCT00151996 Org: User:
Start: 08/16/04 End: 12/27/04 Due: 12/27/05

Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood

Phase: N/A Priority: Normal
NCT ID: NCT00150566 Org: User:
Start: 02/09/04 End: 10/08/05 Due: 10/08/06

Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder

Phase: N/A Priority: Normal
NCT ID: NCT04866043 Org: User:
Start: 06/01/19 End: 10/15/21 Due: 10/15/22

Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community Setting

Phase: N/A Priority: Normal
NCT ID: NCT03336450 Org: User:
Start: 04/23/18 End: 10/13/20 Due: 10/13/21